Arrow Declarations - Teva UK v Novartis
Author Dfrg.msc Public Domain Source Wikimedia Commons Jane Lambert Court of Appeal (Lords Justices Arnold and Nugee and Sir Christopher Floyd) Teva UK Ltd and another v Novartis AG [2022] EWCA Civ 1617 (8 Dec 2022) This was an appeal against Mrs Justice Bacon's refusal to grant an Arrow declaration in Teva UK Ltd and another v Novartis AG [2022] EWHC 2779 (Ch) (19 Oct 2022). Lord Justice Arnold defined an Arrow declaration as "a declaration that a product, process or use was lacking in novelty or obvious as at the priority date of a patent application" at para [17] of his judgment in Teva UK Ltd and another v Novartis AG [2022] EWCA Civ 1617. He explained that Arrow declarations take their name from the seminal decision of Kitchin J (as he then was) in Arrow Generics Ltd v Merck & Co Inc [2007] EWHC 1900 (Pat), [2008] Bus LR 487. He continued: "The point of such declaration is that it is in effect a declaration that the claimant will have a Gi